USPTO serial 97484081
KIROMIC
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 15, 2025
- Examiner
- MICKLEBURGH, LINDA BOHANNON
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with KIROMIC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karen Won
Karen Won MINTZ, LEVIN, COHN, FERRIS, GLOVSKY, AND POPEO P.CONE FINANCIAL CENTERBOSTON, MA 02111United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical, biologic, and biopharmaceutical preparations for use in oncology, immunology, and immuno-oncology; Biopharmaceutical preparations, cell therapies, and gene therapies for preventing, managing, and treating diseases and disorders in oncology, immunology, and immuno-oncology; Biopharmaceutical preparations in the nature of T-cell allogenic therapies; Biological compounds in the nature of human cells used for enhanced delivery of therapeutic agents to targeted cells within the human body; Biological components, namely, engineered and edited human cells, being a component in therapeutic preparations for use in diseases and disorders of oncology, immunology, and immune-oncology; Therapeutic preparations in the nature of cell therapies for enhancing the targeting, delivery, and effectiveness of cancer treatments; Therapeutic agents for destroying tumor cells and inhibiting tumor growth; Human cells for medical and therapeutic use; T-cells for medical and therapeutic use | ACTIVE | Dec 9, 2024 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 15, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 15, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 21, 2025 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Mar 21, 2025 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Mar 12, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 12, 2025 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 12, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Mar 12, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 7, 2025 | IUAF | USE AMENDMENT FILED | — |
| Jan 7, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jan 7, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jan 7, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 18, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 18, 2024 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jul 18, 2024 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jul 18, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 14, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 12, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 12, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 12, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 11, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 8, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 8, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 8, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 24, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 29, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 29, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 9, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 21, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 20, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 20, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 20, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 5, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 5, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 5, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 3, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 21, 2022 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jul 20, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 4, 2022 | NWAP | NEW APPLICATION ENTERED | — |